Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study

Pediatric Pulmonology

Volumn 45, Issue 6, 2010, Pages 536-540

  Weiss, Batia ^a,b   Bujanover, Yoram ^a   Yahav, Yaakov ^a,b   Vilozni, Daphna ^a,b   Fireman, Elizabeth ^c   Efrati, Ori ^a,b  

^a Safra Children's Hospital   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Laboratory Pulmonary and Allergic Diseases   (Israel)

Author keywords

Cystic fibrosis; Interleukin 8; Probiotics; Pulmonary; Sputum

Indexed keywords

AZITHROMYCIN; INTERLEUKIN 8; PROBIOTIC AGENT;

ADULT; ANALYTICAL PARAMETERS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FLATULENCE; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LUNG DISEASE; LUNG FUNCTION TEST; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUANTITATIVE ANALYSIS; SPUTUM ANALYSIS; SPUTUM CULTURE; STREPTOCOCCUS THERMOPHILUS; SUPPLEMENTATION;

ADULT; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MUTATION; NEUTROPHILS; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; SPUTUM; YOUNG ADULT;

EID: 77953320256     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21138     Document Type: Article

References (34)

1. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-188.
2. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with pseudomonas aeruginosa. J Pediatr 1990;116: 714-719.
3. Wilmott RW, Tyson SL, Matthew DJ. Cystic fibrosis survival rates. The influence of allergy and Pseudomonas aeruginosa. Am J Dis Child 1985;139:669-671. (Pubitemid 15006401)
4. Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004;20:813-819.
5. Infante Pina D, Redecillas Ferreiro S, Torrent Vernetta A, Segerra Canton O, Maldonado Smith M, Gartner Tizziano L, Hidalgo Albert E. Improvement of intestinal function in cystic fibrosis patients using probiotics. Ann Pediatr (Barc) 2008;69:501-505.
6. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2004;CD003048.
7. Guandalini S. Probiotics for children with diarrhea: an update. J Clin Gastroenterol 2008;42:S53-S57.
8. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management and prevention of atopic eczema. Clin Exp Allergy 2000;30:1604-1610.
9. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolaury E. Probiotica and prevention of atopic disease: 4-years follow-up of a randomized placebo-controlled trial. Lancet 2003;361:1869-1871.
10. Elahi B, Nikfar S, Derakhshani S, Vafaie M, Abdollahi M. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2008;53:1278-1284.
11. Neil FR, Albert DL. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. J Clin Gastroenterol 2008;42:S97-S103.
12. Isolauri E, Majamma H, Arvola T, Rantaia I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reversed increased intestinal permeabiltiy induced by cow milk in suckling rats. Gastroenterology 1993;105:1643-1650. (Pubitemid 24002779)
13. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Interest Microbiol 2001;1: 27-42.
14. Di Caro S, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR, Gasbarrini A. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 2005;37:320-329.
15. Van Elburg RM, Uil JJ, Van Aalderen WMC, Mulder CJJ, Heymans HSA. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediatr Res 1996;39:985-991.
16. Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B, Van Cauwenberge P, Bachert C. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35:467-472.
17. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, Guarino A. Effect of Latobaciullus GG supplementation on pulmonary exacerbation in patients with cystic fibrosis: a pilot study. Clin Nutr 2007;26:322-328.
18. Carrabino S, Carpani D, Livraghi A, Di Cicco M, Costantini D, Coperi E, Colombo C, Conese M. Dysregulated interleukin-8 secretion and NF-activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibrosis 2006;5:113-119.
19. Hoiby N. Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis. Pediatr Drugs 2000; 2:451-463.
20. Cystic Fibrosis Foundation. Microbiology and infectious disease in Cystic Fibrosis. Consensus Conference: concept in care, vol V, sec1, Bethesda, 1994.
21. Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 2004;37:393-399.
22. Kube D, Sontich U, Fletcher D, Davis P. Proinflammatory cytokine responses to P. aeuroginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 2001; 280:L493-502.
23. Kammouni W, Figarella C, Marchand S, Mertem M. Altered cytokine production by cystic fibrosis tracheal gland serous cell. Infect Immun 1997;65:5176-5183. (Pubitemid 27513567)
24. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999;104:72-78.
25. Tabary O, Zahm JM, Hinnrasly J, Couetil JP, Cornillet P, Guenouno M, Gaillard D, Puchelle E, Jacquot J. Selective upregulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998;153: 921-930. (Pubitemid 28419044)
26. Tabary O, Escotte S, Couetil JP, Hubert D, Dusser D, Puchelle E, Jacquot J. Genistein inhibits constitutive and inducible NF-κB activation and decreased IL-8 production by human cystic fibrosis bronchial gland cells. Am J Pathol 1999;155:473-481. (Pubitemid 29370397)
27. Jacquot J, Tabary O, Le Rouzic P, Clement A. Airway epithelial cell inflammatory signaling in cystic fibrosis. Int J Biochem Cell Biol 2008;40:1703-1715.
28. Papas KA, Sontag MK, Pardee C, Sokol RJ, Sagel SD, Acuurso FJ, Wagener JS. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J Cyst Fibros 2008;7:60-67.
29. Dixon WJ (Chief Editor). BMDP Statistical Software. Los-Angeles: University of California Press; 1993.
30. Alverez S, Herrero C, Bru E, Perdigon G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J Food Prot 2001;11:1768-1774. (Pubitemid 34010095)
31. Valdez JC, Peral MC, Rachid M, Santana M, Perdigon G. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect 2005;11: 472-479.
32. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-α and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006;130:731-746.
33. Isolauri E, Salminen S. Probitics, gut inflammation and barrier function. In: Gastroenterology Clinics of North America, G Fridman, Ed. Vol. 34. Philadelphia: Elsevier; 2005. pp 437-450.
34. Raia V, Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Auricchio S, Cimmino M, Cavaliere M, Nardone M, Cesaro A, Malcolm J, Quaratino S, Londei M. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax 2005;60:773-780.